Supplementary Protection Certificate Search
Details
- SPC number
- SPC/GB14/062
- Filing date
- 12 September 2014
Applicant(s) details
- Name
-
Merck Sharp & Dohme Corp.
- Address
-
126 East Lincoln Avenue
Rahway
New Jersey 07065
United States of America
Agent details
- Name
-
Merck Sharp & Dohme LLC
- Address
-
120 Moorgate
London
EC2M 6UR
Patent details
- Patent number
- EP0720599
- Title
-
Hydroxy- substituted azetidinone compounds useful as hypocholestrolemic agents.
UK authorisation details
- Authority date
- 10 September 2014
- UK authorisations
- DE/H/3895-3898/001DC
- DE/H/3895-3898/002DC
- DE/H/3895-3898/003DC
- DE/H/3895-3898/004DC
Product details
- Product description
-
Ezetimibe and atorvastatin or pharmaceutically acceptable salts thereof, including atorvastatin as atorvastatin as atorvastatin calcium trihydrate. Active ingredients:ezetimibe and atorvastatin calcium trihydrate. Proprietary name: ATOZET
- Status
- Lodged
- Product type
- Medicinal
Life details
- In force date
- Actual expiry date
- Maximum expiry date
- Invalid date
- Lapsed date
- Lapsed status
-
Extension details
- Lodged date
- Granted date
- Refused date
- Revoked date
- Expiry date
- Authorisation number
- Authorisation date
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.